Related Experiment Videos
Cardiological hypertensive emergencies: Real word data compared to guidelines indications
Filippo Brucato1, Chiara Tognola2, Lorenzo De Censi1
1School of Medicine and surgery, University of Milano-Bicocca, Milan, Italy.
Insights
Cardiological Hypertensive Emergencies (CHE) management shows a persistent gap between guidelines and practice. Lower target achievement in 2019 indicates incomplete adoption of aggressive blood pressure goals in emergency care.
Area of Science:
- Cardiology
- Emergency Medicine
- Hypertension Management
Background:
- Cardiological Hypertensive Emergencies (CHE) involve severely high blood pressure with acute cardiac damage.
- Evaluating CHE prevalence, clinical features, and real-world blood pressure management is crucial.
Purpose of the Study:
- To assess the prevalence, clinical features, and blood pressure management of CHE.
- To compare emergency department (ED) practice adherence to guidelines before and after 2017.
Main Methods:
- Retrospective analysis of adult patients with severe hypertension and cardiac damage in 2017 and 2019.
- Defined target achievement based on SBP reduction (2017) and specific BP thresholds (2019).
Main Results:
- 282 CHE cases analyzed, representing half of all hypertensive emergencies.
- Nitroglycerin was the primary IV therapy; short-acting nifedipine use decreased.
- Lower target achievement in 2019 due to more stringent BP goals.
Conclusions:
- A gap persists between CHE guideline recommendations and clinical practice.
- Reduced target achievement in 2019 suggests incomplete adoption of aggressive BP targets.
- Potential reasons include hypoperfusion concerns, limited guideline dissemination, or documentation differences.
Background:
Cardiological Hypertensive Emergencies (CHE) are characterized by markedly elevated blood pressure (BP) values associated with acute cardiac hypertension-mediated organ damage (acute coronary syndrome, acute heart failure, acute pulmonary edema, or aortic dissection). This study aimed to evaluate the prevalence, clinical features and real-world BP management of CHE and to assess adherence to guideline recommendations by comparing ED practice before and after recent guideline release (2017 vs 2019).
Methods:
This single-center retrospective analysis included all adult patients admitted to the ED of Niguarda Hospital, Milan, during 2017 and 2019 with severely elevated BP (SBP ≥180 mmHg and/or DBP ≥120 mmHg) and acute cardiological organ damage. Target achievement was defined as ≥25% SBP reduction for 2017 and SBP <140 mmHg (<120 mmHg for aortic dissection) for 2019.
Results:
282 CHE were analysed representing nearly half of all hypertensive emergencies in both years. Nitroglycerin was the predominant intravenous therapy used. Short-acting nifedipine use strongly decrease from 2017 to 2019. Baseline BP values were 193.2/95.2 ± 14.2/17.4 mmHg and decreased significantly during the ED stay (∆ 37.4/17.1 vs 26.0/20.4 mmHg). The proportion of patients achieving guideline-defined targets was lower in 2019, reflecting the introduction of more stringent BP goals.
Conclusions:
This real-world analysis demonstrates a persistent gap between guideline recommendations and clinical practice in the management of CHE. The reduced target achievement in 2019 suggests that the adoption of aggressive BP targets remains incomplete, potentially due to concerns regarding hypoperfusion, limited dissemination of guideline updates or differences in documentation.
Related Concept Videos
Introduction Cardiac Emergencies
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy II: Dilated Cardiomyopathy
Pre-Procedural Guidelines for Assessing Blood Pressure